About the Authors
- Liyong Wu
-
Affiliations Translational Neuroimaging Laboratory, Douglas Hospital, McGill University, Montreal, Quebec, Canada, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada, Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China
- Jared Rowley
-
Affiliations Translational Neuroimaging Laboratory, Douglas Hospital, McGill University, Montreal, Quebec, Canada, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada
- Sara Mohades
-
Affiliations Translational Neuroimaging Laboratory, Douglas Hospital, McGill University, Montreal, Quebec, Canada, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada
- Antoine Leuzy
-
Affiliations Translational Neuroimaging Laboratory, Douglas Hospital, McGill University, Montreal, Quebec, Canada, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada
- Marina Tedeschi Dauar
-
Affiliations Translational Neuroimaging Laboratory, Douglas Hospital, McGill University, Montreal, Quebec, Canada, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada
- Monica Shin
-
Affiliations Translational Neuroimaging Laboratory, Douglas Hospital, McGill University, Montreal, Quebec, Canada, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada
- Vladimir Fonov
-
Affiliation McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
- Jianping Jia
-
Affiliation Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China
- Serge Gauthier
-
Affiliation McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada
- Pedro Rosa-Neto
-
* E-mail: pedro.rosa@mcgill.ca
Affiliations Translational Neuroimaging Laboratory, Douglas Hospital, McGill University, Montreal, Quebec, Canada, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada, McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
- the Alzheimer’s Disease Neuroimaging Initiative
Competing Interests
The Alzheimer’s Disease Neuroimaging Initiative study received funding for data collection and sharing from commercial sources (Abbott; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. ). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: LW PR. Performed the experiments: JR LW. Analyzed the data: JR LW PR. Contributed reagents/materials/analysis tools: SM MS VF PR JR. Wrote the paper: LW SM AL MD MS JJ SG PR.